<DOC>
	<DOCNO>NCT02419872</DOCNO>
	<brief_summary>The study evaluate percentage patient asthma COPD achieve disease control</brief_summary>
	<brief_title>Study Patients ' With Persistent Asthma Chronic Obstructive Pulmonary Disease</brief_title>
	<detailed_description>There treatment group intervention patient randomly assign . Data collect routine setting single occasion otherwise normal visit physician 's office clinic . Participating physician perform medical procedure outside normal daily clinical practice . All treatment decision sole discretion participate physician reflect current standard care</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Patient ≥ 18 year age diagnose persistent asthma patient ≥ 40 year age and/or ( ex ) smoker 10 pack year smoke diagnose COPD Treatment stable dose ( change dose change le 50 % last 3 month ) Inhaled corticosteroid ( ICS ) , Longacting beta2agonists ( LABA ) , Fixed dose combination ( FDC ) administer twice daily Dry powder inhaler ( DPI ) 3 month prior enrollment accordance approve indication Patient willing able provide write informed consent ; Patient agree participate study disclose medical event treat physician ; Patient able complete questionnaire . • Current enrolment plan enrolment interventional study ( patient allow participate observational casecontrol study ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>